Source: Journal of clinical endocrinology & metabolism. Unidade: FM
Subjects: MICOSES, DIAGNÓSTICO TARDIO, LINFOMA, LINFÓCITOS T, NEOPLASIAS CUTÂNEAS, PROGNÓSTICO, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALCAO, Camila Kruschewsky et al. Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma. Journal of clinical endocrinology & metabolism, v. 104, n. 8, p. 3245-3248, 2019Tradução . . Disponível em: https://doi.org/10.1210/jc.2018-02221. Acesso em: 03 nov. 2024.APA
Falcao, C. K., Cabral, M. C. S., Mota, J. M., Arbache, S. T., Costa-riquetto, A. D., Muniz, D. Q. B., et al. (2019). Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma. Journal of clinical endocrinology & metabolism, 104( 8), 3245-3248. doi:10.1210/jc.2018-02221NLM
Falcao CK, Cabral MCS, Mota JM, Arbache ST, Costa-riquetto AD, Muniz DQB, Cury-martins J, Almeida MQ, Kaczemorska PC, Nery M. Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma [Internet]. Journal of clinical endocrinology & metabolism. 2019 ; 104( 8): 3245-3248.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1210/jc.2018-02221Vancouver
Falcao CK, Cabral MCS, Mota JM, Arbache ST, Costa-riquetto AD, Muniz DQB, Cury-martins J, Almeida MQ, Kaczemorska PC, Nery M. Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma [Internet]. Journal of clinical endocrinology & metabolism. 2019 ; 104( 8): 3245-3248.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1210/jc.2018-02221
